Retrospective Exploratory Analysis of Donor-derived Cell Free DNA in Liver Transplant Patients
Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Observational
SUMMARY
Determine the levels of Donor-derived (dd)cell-free DNA(cfDNA )in liver transplant recipients with normal liver function tests (LFTs) indicating stable immunosuppression status (IS). Based on this range use the dd-cfDNA levels to determine over or under IS in liver transplant patients to make changes to their IS medication regimen.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age: ≥18 years
• The patient underwent a liver transplant.
• The patient at least has one level of dd-cfDNA documented
Locations
United States
Texas
Methodist Dallas Medical Center
RECRUITING
Dallas
Contact Information
Primary
Kavya Vinod Mankulangara, PharmD
MHSIRB@mhd.com
214-947-4681
Backup
Bethany Brauer, MPH
mhsirb@mhd.com
214-947-4681
Time Frame
Start Date: 2021-07-01
Estimated Completion Date: 2024-12-31
Participants
Target number of participants: 300
Related Therapeutic Areas
Sponsors
Leads: Methodist Health System